BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19248972)

  • 1. Management of resectable gastrointestinal stromal tumor.
    Chaudhry UI; DeMatteo RP
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):79-96, viii. PubMed ID: 19248972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumor: 5 years later.
    van der Zwan SM; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1781-8. PubMed ID: 16136600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of recurrent gastrointestinal stromal tumors.
    Winer JH; Raut CP
    J Surg Oncol; 2011 Dec; 104(8):915-20. PubMed ID: 21337345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS; Dematteo RP
    Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors: imatinib and beyond.
    Schnadig ID; Blanke CD
    Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in therapy for gastrointestinal stromal tumors.
    Maki RG
    Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumor--paradigm for successful targeted therapy.
    Kurian S
    Indian J Gastroenterol; 2007; 26(5):207-8. PubMed ID: 18227567
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
    Demetri GD
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib.
    Cassier PA; Dufresne A; Arifi S; El Sayadi H; Ray-Coquard I; Bringuier PP; Scoazec JY; Alberti L; Blay JY
    Curr Gastroenterol Rep; 2008 Dec; 10(6):555-61. PubMed ID: 19006610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours.
    Iorio N; Sawaya RA; Friedenberg FK
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1376-86. PubMed ID: 24749828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
    Nishida T; Omori T; Ueshima S
    Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors and leiomyosarcomas.
    Katz SC; DeMatteo RP
    J Surg Oncol; 2008 Mar; 97(4):350-9. PubMed ID: 18286477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment progress of gastrointestinal stromal tumor].
    Ji X; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):292-6. PubMed ID: 23536354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of gastrointestinal stromal tumors--a comprehensive review.
    Lai EC; Lau SH; Lau WY
    Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment of gastrointestinal stromal tumors.
    Kingham TP; DeMatteo RP
    Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Therapy of Gastrointestinal Stromal Tumors.
    Rutkowski P; Hompes D
    Surg Oncol Clin N Am; 2016 Oct; 25(4):735-59. PubMed ID: 27591496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.
    Melichar B; Voboril Z; Nozicka J; Ryska A; Urminská H; Vanecek T; Michal M
    Intern Med; 2005 Nov; 44(11):1163-8. PubMed ID: 16357454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.
    De Giorgi U; Pupi A; Turrisi G; Montenora I; Morini S; Fayyaz M; De Simone M; Fiorentini G
    Rev Recent Clin Trials; 2007 Jan; 2(1):43-8. PubMed ID: 18473987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.
    Eisenberg BL
    Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S24-9. PubMed ID: 17101065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.